haloperidol has been researched along with 3-chlorocarpipramine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morimoto, T; Tadokoro, S; Uchihashi, Y | 1 |
Fukuda, T; Matsubara, S; Mikuni, M; Odagaki, Y; Setoguchi, M; Yamashita, I | 1 |
Yamagami, S | 1 |
1 trial(s) available for haloperidol and 3-chlorocarpipramine
Article | Year |
---|---|
A crossover study of clocapramine and haloperidol in chronic schizophrenia.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Basal Ganglia Diseases; Chronic Disease; Dibenzazepines; Drug Evaluation; Female; Haloperidol; Humans; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Tranquilizing Agents | 1985 |
2 other study(ies) available for haloperidol and 3-chlorocarpipramine
Article | Year |
---|---|
[Effects of mosapramine (Y-516), a new dopamine D2 antagonist, on reverse tolerance after repeated administration of methamphetamine by means of the ambulation-increasing effect in mice].
Topics: Animals; Benzazepines; Chlorpromazine; Dibenzazepines; Dopamine Antagonists; Drug Tolerance; Drugs, Chinese Herbal; Haloperidol; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred Strains; Tranquilizing Agents | 1992 |
Pharmacological and biochemical properties of iminodibenzyl antipsychotic drugs including Y-516 and clocapramine.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Benzylamines; Dibenzazepines; Haloperidol; Male; Promazine; Rats; Rats, Inbred Strains; Sulpiride | 1986 |